Reye's syndrome: mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate
- PMID: 3080954
- DOI: 10.1016/0003-9861(86)90646-6
Reye's syndrome: mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate
Abstract
The effects of Reye's plasma, allantoin, and salicylates on mitochondrial structure and Ca2+ transport have been investigated. Measurements of Ca2+ transport showed that when 20-30 microM Ca2+ was added to isolated rat liver mitochondria preincubated with one of these agents, Ca2+ uptake was followed by its spontaneous release into the medium. This was accompanied by large-amplitude swelling; the onset preceded the Ca2+ release. No further Ca2+ release was induced by uncoupler or the Ca2+ ionophore, A23187. The mitochondria continued to swell even after all of the Ca2+ had been released. The time between the addition of Ca2+ and the onset of swelling (or Ca2+ release) depended on the concentration of the agent added and the preincubation time; the extent of swelling did not. These effects were prevented, but not reversed, by ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid, ruthenium red, rotenone, or adenine nucleotides. The massive swelling and membrane disruption were confirmed by electron microscopy of the treated vs untreated mitochondria. Similar results concerning swelling and Ca2+ release were also seen with Ca2+ alone, but the time scale was much longer (i.e., greater than 3-4 min), indicating that these agents act by potentiating Ca2+-induced alterations in mitochondrial structure, as suggested by our earlier work (T.Y. Segalman and C.P. Lee (1982) Arch. Biochem. Biophys. 214, 522-530; M.E. Martens and C.P. Lee (1984) Biochem. Pharmacol. 33, 2869-2876). Our data show, therefore, that allantoin, salicylates, and the "toxic" agent in Reye's plasma severely limit the ability of isolated rat liver mitochondria to maintain their structural integrity under conditions of limited Ca2+ loading.
Similar articles
-
Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.Med Toxicol Adverse Drug Exp. 1989 Jul-Aug;4(4):272-94. doi: 10.1007/BF03259913. Med Toxicol Adverse Drug Exp. 1989. PMID: 2671597 Review.
-
Reye's syndrome: salicylates and mitochondrial functions.Biochem Pharmacol. 1984 Sep 15;33(18):2869-76. doi: 10.1016/0006-2952(84)90209-0. Biochem Pharmacol. 1984. PMID: 6477646
-
Reye's syndrome: plasma-induced alterations in mitochondrial structure and function.Arch Biochem Biophys. 1982 Apr 1;214(2):522-30. doi: 10.1016/0003-9861(82)90056-x. Arch Biochem Biophys. 1982. PMID: 6178367 No abstract available.
-
Salicylate and mitochondrial injury in Reye's syndrome.Science. 1983 Jul 8;221(4606):163-5. doi: 10.1126/science.6857275. Science. 1983. PMID: 6857275
-
The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury.Mol Cell Biochem. 1997 Sep;174(1-2):159-65. Mol Cell Biochem. 1997. PMID: 9309681 Review.
Cited by
-
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.Prog Lipid Res. 2015 Jul;59:106-25. doi: 10.1016/j.plipres.2015.05.002. Epub 2015 Jun 11. Prog Lipid Res. 2015. PMID: 26073454 Free PMC article. Review.
-
Aspirin and Reye syndrome: a review of the evidence.Paediatr Drugs. 2007;9(3):195-204. doi: 10.2165/00148581-200709030-00008. Paediatr Drugs. 2007. PMID: 17523700 Review.
-
Fisetin Confers Cardioprotection against Myocardial Ischemia Reperfusion Injury by Suppressing Mitochondrial Oxidative Stress and Mitochondrial Dysfunction and Inhibiting Glycogen Synthase Kinase 3β Activity.Oxid Med Cell Longev. 2018 Feb 25;2018:9173436. doi: 10.1155/2018/9173436. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29636855 Free PMC article.
-
The renal mitochondrial dysfunction in patients with vascular calcification is prevented by sodium thiosulfate.Int Urol Nephrol. 2016 Nov;48(11):1927-1935. doi: 10.1007/s11255-016-1375-z. Epub 2016 Jul 27. Int Urol Nephrol. 2016. PMID: 27465796
-
Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.Med Toxicol Adverse Drug Exp. 1989 Jul-Aug;4(4):272-94. doi: 10.1007/BF03259913. Med Toxicol Adverse Drug Exp. 1989. PMID: 2671597 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous